Found: 8
Select item for more details and to access through your institution.
Mesenchymal stem cell therapy alleviates the neuroinflammation associated with acquired brain injury.
- Published in:
- CNS Neuroscience & Therapeutics, 2020, v. 26, n. 6, p. 603, doi. 10.1111/cns.13378
- By:
- Publication type:
- Article
Traumatic brain injury.
- Published in:
- CNS Neuroscience & Therapeutics, 2020, v. 26, n. 6, p. 593, doi. 10.1111/cns.13397
- By:
- Publication type:
- Article
Immunization with neural‐derived peptides increases neurogenesis in rats with chronic spinal cord injury.
- Published in:
- CNS Neuroscience & Therapeutics, 2020, v. 26, n. 6, p. 650, doi. 10.1111/cns.13368
- By:
- Publication type:
- Article
(−)‐Phenserine tartrate (PhenT) as a treatment for traumatic brain injury.
- Published in:
- CNS Neuroscience & Therapeutics, 2020, v. 26, n. 6, p. 636, doi. 10.1111/cns.13274
- By:
- Publication type:
- Article
Potential of mesenchymal stem cells alone, or in combination, to treat traumatic brain injury.
- Published in:
- CNS Neuroscience & Therapeutics, 2020, v. 26, n. 6, p. 616, doi. 10.1111/cns.13300
- By:
- Publication type:
- Article
Cell therapy for central nervous system disorders: Current obstacles to progress.
- Published in:
- CNS Neuroscience & Therapeutics, 2020, v. 26, n. 6, p. 595, doi. 10.1111/cns.13247
- By:
- Publication type:
- Article
Role of the PGE<sub>2</sub> receptor subtypes EP1, EP2, and EP3 in repetitive traumatic brain injury.
- Published in:
- CNS Neuroscience & Therapeutics, 2020, v. 26, n. 6, p. 628, doi. 10.1111/cns.13228
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- CNS Neuroscience & Therapeutics, 2020, v. 26, n. 6, p. 495, doi. 10.1111/cns.13168
- Publication type:
- Article